RGS10 and ovarian carcinoma: Further investigation demonstrated the contribution of HDAC1 and DNMT1 to silencing of RGS10 during acquired chemo-resistance and revealed the importance of HDAC1 and DNMT1 inhibition as an assistant therapeutic approach to overcome ovarian cancer chemo-resistance (32).